Cat. No. | Name/Description | Purity |
---|---|---|
A1719304 | Enbezotinib (enantiomer) | 98% |
A1173510 | Pz-1 | 99% |
A1176675 | SPP-86 | 99% |
A1329297 | Fedratinib hydrochloride hydrate | 97% |
A1324667 | JNJ-38158471 | 98% |
A345883 | Fedratinib | 98% |
A177150 | Regorafenib | 98% |
A1949837 | BT44 | 98% |
A1145218 | Selpercatinib | 98% |
A2667069 | Selpercatinib | 99% |
A248926 | AST 487 | 98% |
A1275491 | RET V804M-IN-1 | 98+% |
A144993 | Agerafenib | 98% |
A395008 | Danusertib | 99+% |
A469558 | TG101209 | 98+% |
A723612 | GSK3179106 | 98% |
A1374317 | RET-IN-3 | 98+% |
A984305 | BBT594 | 98+% |
A712840 | AD80 | 99+% |
A468588 | Pralsetinib | 99% |
Name/Description | c-RET ↓ ↑ | Other Targets | Purity | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regorafenib |
+++
RET, IC50: 1.5 nM |
98% | |||||||||||||||||
TG101209 |
++
RET, IC50: 17 nM |
FLT3 | 99%+ | ||||||||||||||||
Danusertib |
+
RET, IC50: 31 nM |
99%+ | |||||||||||||||||
AD80 |
++++
RET wt, IC50: 1.3 nM RET V804M, IC50: 0.6 nM |
Src,Raf | 99+% | ||||||||||||||||
1. Hovering the mouse over the "+" can display the specific value of the relevant IC50. The more "+", the stronger the inhibitory effect. 2. "✔" Indicates that the compound has inhibitory effects on the corresponding subtypes, but there is currently no relevant data on the intensity of inhibition. |